Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
LOADING
|||
Gross Profit Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
26.81%
↓ 49% below average
Average (9y)
52.79%
Historical baseline
Range
High:166.31%
Low:-18.72%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 26.81% |
| 2023 | 74.75% |
| 2022 | 23.36% |
| 2021 | 69.75% |
| 2020 | 113.06% |
| 2019 | 166.31% |
| 2018 | -4.49% |
| 2017 | 62.31% |
| 2016 | 14.75% |
| 2015 | -18.72% |